Photo of Christopher Walsh

Christopher Walsh

  • ASSOCIATE PROFESSOR Medicine, Hematology and Medical Oncology
Print ProfilePrint Profile

Certifications

  • Hematology

  • American Board of Internal Medicine

Education

  • MD, Tulane University

  • A.B., Rutgers College

  • Ph.D, Bowman Gray School of Medicine
    Biochemistry

  • Internship, Internal Medicine
    North Carolina Memorial Hospital

  • Residency, Internal Medicine
    North Carolina Memorial Hospital

  • Residency, Internal Medicine
    National Institutes of Health

  • Fellowship, Hematology
    National Institutes of Health

Research

Research

Dr. Walsh directs the Hemophilia Program in the Division of Hematology and Medical Oncology at Mount Sinai School of Medicine. His research focuses on gene therapy of blood diseases. Throughout his career he has had a particular interest in Fanconi anemia and his early work in this area culminated in the first clinical trial in which retroviral vectors were used for gene therapy of patients with Fanconi anemia group C. He is also actively developing gene therapies for hemophilia A and B. 

Publications

Walsh CE. Fetal gene therapy- a perspective. Gene Ther 1999; 6: 1200-01.

Chao HJ, Walsh CE. Canine FIX antigen in Chapel Hill strain hemophilia B canine. Haemostasis and Thrombosis 1999; 82: 1378.

Walsh CE, Yountz M, Simpson DE. Cellular localization of Fanconi anemia group A protein. Bioch Biophys Res Commun 1999; 259: 594-599.

McMahon LW, Walsh CE, Lambert M. Human alpha spectrin II and the Fanconi anemia proteins FANCA and FANCC interact to form a nuclear complex. J Biol Chem 1999; 274: 32904-08.

Gush K, Fu KL, Grompe M, Walsh CE. Phenotypic correction of Fanconi anemia group C knockout mice. Blood 2000; 95: 700-704.

Chao HJ, Mao L, Bruce AT, Walsh CE. Sustained expression of human factor VIII in mice using a parvovirus-based vector. Blood 2000 Mar; 95(5): 1594-1599.

Chao HJ, Liu Y, Rabinowitz J, Li C, Samulski RJ, Walsh CE. Several log increase in therapeutic transgene delivery by distinct adeno-associated viral serotype vectors. Mol Ther 2000; 2(6): 619-623.

Yamada K, Olsen JC, Rao K, Walsh CE. Functional correction of Fanconi anemia group C hematopoietic cells using lentiviral vectors. Mol Ther 2001; 3: 485-90.

Chao HJ, Walsh CE. Induction of tolerance to human factor VIII in mice. Blood 2001; 97(10): 3311-2.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Walsh during 2012 and/or 2013. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Consulting:

  • Baxter; F. Hoffman-La Roche Ltd.; Gerson Lehrman Group; Pfizer Inc.

Scientific Advisory Board:

  • Baxter; Bayer; CSL Behring; Novo Nordisk

Industry-Sponsored Lectures: MSSM faculty occasionally give lectures at events sponsored by industry, but only if the events are free of any marketing purpose.

  • Novo Nordisk; Pfizer Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.

Edit profile in Sinai Central

Address

Annenberg Building Floor 24 Room 04A
1468 Madison Avenue
New York, NY 10029


Address

Faculty Practice Associates Floor 12th Floor Room Clinic Area
5 East 98th Street
New York, NY 10029


Address

Annenberg Building Floor 24th Room 130E
1468 Madison Avenue
New York, NY 10029

Tel: 212-241-3443
Fax: 212-241-4096
Address

5 East 98th Street
12th Floor
New York, NY 10029

Tel: 212-241-8303
Fax: 212-722-6079
Get Directions
Insurance Plans
  • Aetna
  • Best Doctor
  • Blue Cross/ Blue Shield - HMO
  • CIGNA Healthcare HMO
  • CarePlus, LLC
  • Empire Blue Cross/ Blue Shield - HMO
  • Fidelis Care NY - HMO
  • GHI HMO Select, Inc.
  • HealthFirst PHSP, Inc.
  • Healthnet-Empire BCBS -HMO
  • Medicaid
  • Medicare
  • Neighborhood Health Providers, LLC
  • Oxford Health Plans
  • United Health Care Empire Plan - HMO
  • United Healthcare

Department of Medicine - Hematology

5 East 98th Street
12th Floor
New York, NY 10029

Tel: 212-241-8303
Fax: 212-722-6079
Get Directions